Active

Boehringer Ingelheim Veterinary Medicine Belgium NV

Switched

BE0842800336

Rechtspersoon Public limited company 1 establishment

Noorwegenstraat 4, 9940 Evergem Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

14 year, 7 months

Financials

Financial year 2025

Gross margin

€ 0

Profit

Healthy

€ 486,745

▼ 35% vs 2024

Debts

Low

€ 941,343

▲ 16% vs 2024

Boehringer Ingelheim Veterinary Medicine Belgium NV from Evergem, company number BE0842800336, closed financial year 2025 with a result of € 486,745 after tax. For that financial year Boehringer Ingelheim Veterinary Medicine Belgium NV recorded a gross margin of € 0 and equity of € 5.6 million. Compared with financial year 2024, the result moved from € 752,127 to € 486,745. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What happened at Boehringer Ingelheim Veterinary Medicine Belgium NV?

What happened at Boehringer Ingelheim Veterinary Medicine Belgium NV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Carla Ramon stepped down as director. NBB
  • Friedrich Kaess stepped down as director. NBB
  • Lukas Hauschild stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 486,745 (▼ 35% vs 2024). Source: NBB ↗
  • Christoph Tautphäus stepped down as director. NBB
  • Lukas Hauschild became a director. NBB
  • Larisa Nurkanovic stepped down as director. NBB
  • Silke Seeber stepped down as director. NBB

In short

From € 656,266 profit in 2021 to € 486,745 profit in 2025.

Paid € 663 in corporate taxes since 2021.

Best year ever: 2024, with € 752,127 profit.

Pays suppliers within 63 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at Boehringer Ingelheim Veterinary Medicine Belgium NV? We notify you, reason included.

Follow Boehringer Ingelheim Veterinary Medicine Belgium NV

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Boehringer Ingelheim Vetmedica GmbH 100%
Boehringer Ingelheim Veterinary Medicine Belgium NV

The shares are held by Boehringer Ingelheim Vetmedica GmbH (100%).

See the full network in the app

Directors

According to the 2025 annual accounts

Silke Seeber

Managing director

since 2023 · until 2026

Sebastian Guijarro

Director

since 2024 · until 2025

Friedrich Kaess

Managing director

since 2026 · until 2029

Carla Ramon

Director

Also active at: Boehringer Ingelheim Animal Health Belgium SA, BOEHRINGER INGELHEIM CENTRE SA

since 2025 · until 2030

Chiedza Kaitano

Director

Also active at: BOEHRINGER INGELHEIM CENTRE SA

since 2024 · until 2025

Larisa Nurkanovic

Director

Also active at: BOEHRINGER INGELHEIM CENTRE SA

since 2025 · until 2026

Christoph Tautphäus

Director

Also active at: Boehringer Ingelheim SComm, BOEHRINGER INGELHEIM CENTRE SA

since 2025 · until 2026

Lukas Hauschild

Director

since 2026 · until 2029

Shareholders

Boehringer Ingelheim Vetmedica GmbH

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Noorwegenstraat 4

9940 Evergem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.

LABORATORIUM M. NUYTINCK

€ 24.5 million revenue · 2025

LABO VOOR KLINISCHE BIOLOGIE

€ 3.6 million gross margin · 2025

POST VERBA VERBERA

€ 4.5 million revenue · 2025

ANABIOTEC

€ 9 million gross margin · 2025

Group Nuytinck

+5 more

Details

Company number
0842.800.336
VAT number
BE 0842.800.336
Registered office
Noorwegenstraat 4, 9940 Evergem
Names & denominations
Boehringer Ingelheim Veterinary Medicine Belgium NV · BIVMB
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
17 January 2012
Peppol
Active · Active since 30 Mar 2026
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Diensten in verband met de verzorging van huisdieren, muv veterinaire diensten

Vervaardiging van overige farmaceutische producten

Vervaardiging van geneesmiddelen

Vervaardiging van farmaceutische grondstoffen

Diensten in verband met de verzorging van huisdieren, m.u.v. veterinaire diensten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of Boehringer Ingelheim Veterinary Medicine Belgium NV?
The enterprise number of Boehringer Ingelheim Veterinary Medicine Belgium NV is BE0842800336.
What is the address of Boehringer Ingelheim Veterinary Medicine Belgium NV?
The registered office of Boehringer Ingelheim Veterinary Medicine Belgium NV is located at Noorwegenstraat 4, 9940 Evergem.
When was Boehringer Ingelheim Veterinary Medicine Belgium NV founded?
Boehringer Ingelheim Veterinary Medicine Belgium NV was founded on 17 January 2012.
What is the main activity of Boehringer Ingelheim Veterinary Medicine Belgium NV?
The main activity of Boehringer Ingelheim Veterinary Medicine Belgium NV is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does Boehringer Ingelheim Veterinary Medicine Belgium NV have a website?
No website is currently known for Boehringer Ingelheim Veterinary Medicine Belgium NV.
How much profit did Boehringer Ingelheim Veterinary Medicine Belgium NV make in 2025?
Boehringer Ingelheim Veterinary Medicine Belgium NV posted a profit after taxes of € 486,745 in financial year 2025.
How many employees does Boehringer Ingelheim Veterinary Medicine Belgium NV have?
According to the 2025 annual accounts, Boehringer Ingelheim Veterinary Medicine Belgium NV has 17.9 full-time equivalents (FTE).
Where can I find the annual accounts of Boehringer Ingelheim Veterinary Medicine Belgium NV?
Boehringer Ingelheim Veterinary Medicine Belgium NV files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Boehringer Ingelheim Veterinary Medicine Belgium NV?
According to the 2025 annual accounts, the directors of Boehringer Ingelheim Veterinary Medicine Belgium NV are: Silke Seeber, Sebastian Guijarro, Friedrich Kaess, Carla Ramon, Chiedza Kaitano, Larisa Nurkanovic, Christoph Tautphäus, Lukas Hauschild.
Who owns Boehringer Ingelheim Veterinary Medicine Belgium NV?
The shares are held by Boehringer Ingelheim Vetmedica GmbH (100%).
Who are the shareholders of Boehringer Ingelheim Veterinary Medicine Belgium NV?
According to the 2025 annual accounts, the shareholders of Boehringer Ingelheim Veterinary Medicine Belgium NV are: Boehringer Ingelheim Vetmedica GmbH (100%).